Integrative proteo-genomic profiling uncovers key biomarkers of lapatinib resistance in HER2-positive breast cancer
J Steggall, Vinothini Rajeeve, Najah M. Alsubaie, Atif Naeem, Aamer Ikram, Ateequllah Hayat
The paper identifies a nine-marker signature of lapatinib resistance in HER2-positive breast cancer using integrative multi-omics analysis, revealing novel biomarkers and chromatin dynamics associated with drug resistance.
British Journal of Cancer · Sep 13, 2025Peer-reviewedCancer Biology